Evidence map›Paper›PMID 38670253›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2024

Referral and Beyond: Restructuring the Kidney Transplant Process to Support Greater Access in the United States.

Catherine R Butler, Peter P Reese, Xingxing S Cheng

Abstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catherine R ButlerDivision of Nephrology, Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington; Veteran Affairs Health Services Research and Development Center of Innovation for Veteran-Centered and Value-Driven Care, Seattle, Washington.
Peter P ReeseRenal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Bioinformatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Xingxing S ChengDivision of Nephrology, Department of Medicine, Stanford University, Palo Alto, California. Electronic address: xscheng@stanford.edu.

Funding

Strengthening Shared Decision-Making for Older Adults with Kidney Failure Considering Kidney TransplantK23DK129777 · NIDDK · UNIVERSITY OF WASHINGTON · PI Catherine R Butler · 2022 to 2026
$930k
Refining repeat screening for coronary artery disease in kidney transplant candidatesK23DK123410 · NIDDK · STANFORD UNIVERSITY · PI CHENG, XINGXING SHELLEY · 2020 to 2024
$826k
Mentored research in solid organ transplantation: outcomes using organs from Hepatitis C virus infected donors for uninfected recipientsK24AI146137 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI REESE, PETER PHILIP · 2019 to 2023
$671k
The Role of Pretransplant Services on Outcomes and Costs in Kidney TransplantationR03DK134795 · NIDDK · STANFORD UNIVERSITY · PI CHENG, XINGXING SHELLEY · 2023 to 2024
$244k
NIAID NIH HHS K24 AI146137NIDDK NIH HHS K23 DK123410NIDDK NIH HHS K23 DK129777NIDDK NIH HHS R03 DK134795
6 · The paper itself

Abstract

Advocates for improved equity in kidney transplants in the United States have recently focused their efforts on initiatives to increase referral for transplant evaluation. However, because donor kidneys remain scarce, increased referrals are likely to result in an increasing number of patients proceeding through the evaluation process without ultimately receiving a kidney. Unfortunately, the process of referral and evaluation can be highly resource-intensive for patients, families, transplant programs, and payers. Patients and families may incur out-of-pocket expenses and be required to complete testing and treatments that they might not have chosen in the course of routine clinical care. Kidney transplant programs may struggle with insufficient capacity, inefficient workflow, and challenging programmatic finances, and payers will need to absorb the increased expenses of upfront pretransplant costs. Increased referral in isolation may risk simply transmitting system stress and resulting disparities to downstream processes in this complex system. We argue that success in efforts to improve access through increased referrals hinges on adaptations to the pretransplant process more broadly. We call for an urgent re-evaluation and redesign at multiple levels of the pretransplant system in order to achieve the aim of equitable access to kidney transplantation for all patients with kidney failure.

Indexed as

Health Services AccessibilityKidney Failure, ChronicKidney TransplantationReferral and ConsultationHumansTissue and Organ ProcurementUnited StatesEquitykidney transplantation

Identifiers

PMID38670253
PMCPMC11499052

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.